切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2026, Vol. 19 ›› Issue (03) : 359 -364. doi: 10.3877/cma.j.issn.1674-6902.2026.03.001

论著

五次坐立试验与中老年人群新发慢性肺部疾病风险的队列研究
万鹏飞, 刘刚, 魏振波, 刘禹, 李琦(), 王关嵩()   
  1. 400037 重庆,陆军(第三)军医大学第二附属医院呼吸与危重症医学科
  • 收稿日期:2026-03-31 出版日期:2026-06-25
  • 通信作者: 李琦, 王关嵩
  • 基金资助:
    重庆市科卫联合医学攻关重大项目(2024GGXM001)

Cohort study on five-time chair stand test performance and incident chronic lung disease in middle-aged and older adults

Pengfei Wan, Gang Liu, Zhenbo Wei, Yu Liu, qi Li(), Guansong Wang()   

  1. Department of Respiratory and Critical Care Medicine Center, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China
  • Received:2026-03-31 Published:2026-06-25
  • Corresponding author: qi Li, Guansong Wang
引用本文:

万鹏飞, 刘刚, 魏振波, 刘禹, 李琦, 王关嵩. 五次坐立试验与中老年人群新发慢性肺部疾病风险的队列研究[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(03): 359-364.

Pengfei Wan, Gang Liu, Zhenbo Wei, Yu Liu, qi Li, Guansong Wang. Cohort study on five-time chair stand test performance and incident chronic lung disease in middle-aged and older adults[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2026, 19(03): 359-364.

目的

探讨五次坐立试验(five-time chair stand test, CST)表现与中老年新发慢性肺部疾病(chronic lung disease, CLD)风险的关联及在社区人群早期风险识别中的临床意义。

方法

采用中国健康与养老追踪调查(China Health and Retirement Longitudinal Study, CHARLS)数据库,选择2011年基线调查及2013、2015、2018、2020年随访,年龄≥45岁、基线未报告CLD且关键变量完整参与者10 371例。根据CST分为异常组4 668例(男CST>7.5 s,女CST>9.5 s),正常组5 703例(男CST≤7.5 s,女CST≤9.5 s)。采用Kaplan-Meier法和Log-rank检验比较两组CLD累积发生风险,构建Cox比例风险模型估计风险比(hazard ratio, HR)及95%置信区间(confidence interval, CI)。

结果

随访期间10 371例参与者中1 601例新发CLD,其中异常组870例(18.64%)、正常组731例(12.82%)。异常组较正常组年龄,女性、农村居民、未婚及低教育水平者占比、高血压、糖尿病、心脏病、卒中及相关用药比例高(P<0.05)。受试者工作特征曲线(receiver operating characteristic, ROC)分析显示,男性CST预测新发CLD的曲线下面积(area under the curve, AUC)为0.588(95%CI:0.567~0.610),最佳截断值7.5 s,灵敏度68.35%,特异度44.96%;女性AUC为0.583(95%CI:0.561~0.604),最佳截断值9.5 s,灵敏度41.33%,特异度71.50%。Kaplan-Meier曲线显示,CST异常组无事件生存率低于正常组(Log-rank P<0.001)。Cox回归显示,未调整模型中CST异常与新发CLD风险升高相关(HR=1.509,95%CI:1.368~1.665,P<0.001);调整人口学因素、生活方式、共病及用药情况,关联稳定存在(HR=1.559,95%CI:1.402~1.733,P<0.001)。

结论

基线CST异常是中老年新发CLD风险增加的预测因子。对群体层面风险分层及社区早期识别具有临床意义。

Objective

To investigate the association between five-time chair stand test (CST) performance and the risk of incident chronic lung disease (CLD) in middle-aged and older adults, and to explore its clinical significance for early risk identification in community populations.

Methods

Data were obtained from the China Health and Retirement Longitudinal Study (CHARLS). A total of 10, 371 participants aged ≥45 years at baseline (2011) who were free of CLD and had complete data on key variables were included, with follow-up waves in 2013, 2015, 2018, and 2020. Participants were categorized into an abnormal CST group (n=4 668, male CST>7.5 s, female CST>9.5 s) and a normal CST group (n=5 703, male CST ≤7.5 s, female CST ≤9.5 s). Kaplan-Meier curves and log-rank tests were used to compare cumulative CLD incidence between groups, and Cox proportional hazards models were employed to estimate hazard ratios (HR) and 95% confidence intervals (CI).

Results

During follow-up, 1, 601 out of 10, 371 participants developed incident CLD, including 870 cases (18.64%) in the abnormal CST group and 731 cases (12.82%) in the normal CST group. Compared with the normal group, the abnormal group was older and had higher proportions of females, rural residents, unmarried individuals, those with lower educational levels, and those with hypertension, diabetes, heart disease, stroke, and related medication use (all P<0.05). Receiver operating characteristic (ROC) analysis showed that for males, the area under the curve (AUC) of CST for predicting incident CLD was 0.588 (95%CI: 0.567~0.610), with an optimal cut-off value of 7.5 s, sensitivity of 68.35%, and specificity of 44.96%; for females, the AUC was 0.583 (95%CI: 0.561~0.604), with an optimal cut-off value of 9.5 s, sensitivity of 41.33%, and specificity of 71.50%. Kaplan-Meier curves demonstrated that the abnormal CST group had a significantly lower event-free survival rate than the normal group (log-rank P<0.001). Cox regression showed that in the unadjusted model, abnormal CST was associated with an increased risk of incident CLD (HR=1.509, 95%CI: 1.368~1.665, P<0.001); after adjusting for demographic factors, lifestyle, comorbidities, and medication use, the association remained robust (HR=1.559, 95%CI: 1.402~1.733, P<0.001).

Conclusion

Baseline CST abnormality is a predictor of increased risk of incident CLD in middle-aged and older adults. It holds clinical significance for population-level risk stratification and early community-based identification.

图1 CHARLS数据库10 371例队列筛选流程
表1 两组队列临床资料结果比较
图2 CST预测新发CLD的ROC曲线图。图A为CST预测男性新发CLD的ROC曲线;图B为CST预测女性新发CLD的ROC曲线注:AUC为曲线下面积;CI为置信区间;s为秒;Sensitivity为灵敏度;Specificity为特异度;Cutoff为最佳截断值
图3 两组队列CLD风险Kaplan-Meier生存曲线。图A为两组中男性CLD风险Kaplan-Meier生存曲线;图B为两组中女性CLD风险Kaplan-Meier生存曲线注:Kaplan-Meier curves为Kaplan-Meier生存曲线;Survival probability为生存概率;Number at risk为风险集人数;Time (year)为随访时间(年)
表2 Cox比例风险模型的比例风险假定检验
1
Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study[J]. Lancet Respir Med, 2018, 6(6): 421-430.
2
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
3
Boers E, Barrett M, Su JG, et al. Global burden of chronic obstructive pulmonary disease through 2050[J]. JAMA Netw Open, 2023, 6(12): e2346598.
4
Yu W, Lan Y, Sun D, et al. Prevalence and risk factors for chronic obstructive pulmonary disease among adults aged 50 and above - 10 CKB study areas, China, 2020-2021[J]. China CDC Wkly, 2024, 6(43): 1126-1131.
5
de Oca MM, Perez-Padilla R, Celli B, et al. The global burden of COPD: epidemiology and effect of prevention strategies[J]. Lancet Respir Med, 2025, 13(8): 709-724.
6
Muñoz-Bermejo L, Adsuar JC, Mendoza-Muñoz M, et al. Test-retest reliability of five times sit to stand test (FTSST) in adults: A systematic review and Meta-analysis[J]. Biology(Basel), 2021, 10(6): PMID: 34207604
7
Jones SE, Kon SS, Canavan JL, et al. The five-repetition sit-to-stand test as a functional outcome measure in COPD[J]. Thorax, 2013, 68(11): 1015-1020.
8
Medina-Mirapeix F, Bernabeu-Mora R, Valera-Novella E, et al. The five-repetition sit-to-stand test is a predictive factor of severe exacerbations in COPD[J]. Ther Adv Chronic Dis, 2021, 12: 2040622320986718.
9
Medina-Mirapeix F, Valera-Novella E, Morera-Balaguer J, et al. Prognostic value of the five-repetition sit-to-stand test for mortality in people with chronic obstructive pulmonary disease[J]. Ann Phys Rehabil Med, 2022, 65(5): 101598.
10
Machado A, Dias C, Rebelo P, et al. Functional capacity using sit-to-stand tests in people with chronic obstructive pulmonary disease and its relationship with disease severity-a cross-sectional study with matched controls[J]. Braz J Phys Ther, 2024, 28(4): 101090.
11
Lei X, Sun X, Strauss J, et al. Health outcomes and socio-economic status among the mid-aged and elderly in China: Evidence from the CHARLS national baseline data[J]. J Econ Ageing, 2014, 4: 59-73.
12
Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS) [J]. Int J Epidemiol, 2014, 43(1): 61-68.
13
Feng GY, Li JX, Li GS, et al. Association between frailty status and risk of chronic lung disease: an analysis based on two national prospective cohorts[J]. Aging Clin Exp Res, 2024, 36(1): 215.
14
Li YH, Wang XH, Ya S, et al. The optimal cut-off value of five-time chair stand test for assessing sarcopenia among Chinese community-dwelling older adults[J]. J Cachexia Sarcopenia Muscle, 2024, 15(2): 756-764.
15
Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults[J]. Jama, 2011, 305(1): 50-58.
16
Celis-Morales CA, Welsh P, Lyall DM, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants[J]. Bmj, 2018, 361: k1651.
17
McGrath RP, Kraemer WJ, Snih SA, et al. Handgrip strength and health in aging adults[J]. Sports Med, 2018, 48(9): 1993-2000.
18
Cruz-Jentoft AJ, Sayer AA. Sarcopenia[J]. Lancet, 2019, 393(10191): 2636-2646.
19
Dent E, Martin FC, Bergman H, et al. Management of frailty: opportunities, challenges, and future directions[J]. Lancet, 2019, 394(10206): 1376-1386.
20
Landi F, Salini S, Zazzara MB, et al. Relationship between pulmonary function and physical performance among community-living people: results from Look-up 7+ study[J]. J Cachexia Sarcopenia Muscle, 2020, 11(1): 38-45.
21
Cao Z, Xu C, Zhang P, et al. Associations of sedentary time and physical activity with adverse health conditions: Outcome-wide analyses using isotemporal substitution model[J]. E Clin Med, 2022, 48: 101424.
22
Hanlon P, Lewsey J, Quint JK, et al. Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank[J]. BMJ Open Respir Res, 2022, 9(1): e001314.
23
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission[J]. J Gerontol, 1994, 49(2): M85-M94.
24
Vaidya T, Chambellan A, de Bisschop C. Sit-to-stand tests for COPD: A literature review[J]. Respir Med, 2017, 128: 70-77.
25
Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study[J]. Chest, 2011, 140(2): 331-342.
26
孔令梅,徐晓媛,马丽颖. 慢性阻塞性肺疾病认知衰弱危险因素及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(3): 407-410.
27
徐艳,江秀娟,王超,等. 股直肌剪切波弹性成像对COPD并发肌少症的诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(3): 454-457.
28
Gea J, Agustí A, Roca J. Pathophysiology of muscle dysfunction in COPD[J]. J Appl Physiol, 2013, 114(9): 1222-1234.
29
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol, 2016, 138(1): 16-27.
30
Henrot P, Dupin I, Schilfarth P, et al. Main pathogenic mechanisms and recent advances in COPD peripheral skeletal muscle wasting[J]. Int J Mol Sci, 2023, 24(7): 6454.
[1] 张雅琪, 熊超, 邱琳, 杨蓉. 妊娠期糖尿病孕妇分娩小于胎龄儿的早期生长发育模式[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(06): 643-649.
[2] 谢起根, 苏诚, 徐哲, 李作青. 改良Byars分期尿道成形术与传统术式治疗重型尿道下裂的队列研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 429-435.
[3] 黄远健, 季东健, 封益飞, 孙跃明. 机器人与腹腔镜直肠系膜切除术治疗直肠癌短期结局比较[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 329-334.
[4] 李兴旺, 钟永红, 刘占振, 李月玮, 李庆忠, 姚坤厚, 黄亮. 经肛微创手术(TAMIS)的学习曲线分析[J/OL]. 中华结直肠疾病电子杂志, 2025, 14(04): 353-358.
[5] 吴尧, 赵英涵, 潘哲, 张纯, 李学民, 邱伟强. 浙江省金华市儿童5年眼生物学参数随访近视眼风险评估的流行病学研究[J/OL]. 中华眼科医学杂志(电子版), 2026, 16(01): 9-15.
[6] 崔健, 夏青, 林云, 李光玲, 李心娜, 王位. 血小板与淋巴细胞比值、免疫球蛋白、心肌酶谱及心电图对中老年肝硬化患者病情及预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 400-406.
[7] 汤峥丽, 王芳, 王唯坚. 中老年人群幽门螺杆菌感染对非酒精性脂肪肝及冠状动脉粥样硬化影响的关联性分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 137-140.
[8] 单秋洁, 孙立柱, 徐宜全, 王之霞, 徐妍, 马浩, 刘田田. 中老年食管癌患者调强放射治疗期间放射性肺损伤风险模型构建及应用[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(06): 388-393.
[9] 温欢, 苏博, 刘金波, 王宏宇. 社区中老年人群心踝血管指数纵向轨迹影响因素及与预后的相关性[J/OL]. 中华临床医师杂志(电子版), 2025, 19(09): 642-650.
[10] 李丹, 刘璞娟, 卞亚辉, 张会军, 王莉. 动机性访谈结合阶段性健康教育对冠状动脉旁路移植术后健康行为的影响[J/OL]. 中华临床医师杂志(电子版), 2022, 16(11): 1151-1156.
[11] 李瑞雨, 肖凌勇, 张悦欣, 励志英, 戴晓矞. 浅析醒脑开窍针刺法治疗缺血性脑卒中肢体功能障碍针刺时机研究的思路构建与方案设计[J/OL]. 中华针灸电子杂志, 2023, 12(04): 156-160.
[12] 杜泽宇, 郭恒, 张向辉, 何佳, 木拉提别克·克尔曼, 马儒林, 郭淑霞. 新疆兵团农村居民血脂指标与心血管疾病发病关联的队列研究[J/OL]. 中华心脏与心律电子杂志, 2026, 14(01): 28-35.
[13] 曹箫笛, 王哲. 异常P波额面电轴对不同疾病死亡风险的预测价值[J/OL]. 中华心脏与心律电子杂志, 2023, 11(01): 12-17.
[14] 莫俊贤, 黄东, 冼磊. 胸腔镜与开放手术对5 cm以上R0切除的胸腺肿瘤的回顾性队列研究[J/OL]. 中华胸部外科电子杂志, 2023, 10(01): 7-14.
[15] 陈滢双, 石高羽, 王杭悦, 杨杨, 瞿先国. 社会支持在老年人抑郁与衰弱间的中介作用[J/OL]. 中华老年病研究电子杂志, 2024, 11(01): 18-23.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?